Shamrock International Limited

Shamrock International Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51900MH1994PLC077080 Incorporated 15 March 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Revenue · FY 2025
₹7.47 Cr
▲ 93% YoY
Net profit · FY 2025
₹34.58 Lakh
Net margin 4.6%
EBITDA · FY 2025
₹70.41 Lakh
EBITDA margin 9.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Company age
32 yrs
Est. 1994
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Shamrock International Limited

Data last updated:

Shamrock International Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1994PLC077080. Its GSTIN is 27AAACS5756L1ZW (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Sheetal K Khokhani and Kiran Moreshwar Meher.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹7.47 Cr, a growth of 93% compared to the previous year. For the same year it recorded a net profit of ₹34.58 Lakh (net margin 4.6%) and EBITDA of ₹70.41 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 3% over five years.

Court records list 31 cases involving the company, including 13 filed by the company and 18 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51900MH1994PLC077080
Registration Number 077080
Incorporation Date 15 March 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Shamrock International has one previous CIN (Corporate Identification Number): U51900MH1994PTC077080. The current CIN is U51900MH1994PLC077080, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51900MH1994PLC077080Current
U51900MH1994PTC077080Previous

Contact details

Shamrock International Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    0 – 2 Floor – 0 1/B Vrindavan Chs Laxminarsingh Papan Marg Off. Dr. E. Moses Road Gandhi Naga, R Worli, Mumbai, Maharashtra, India – 400018
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Shamrock International Limited, buy the company report.

Comprehensive company report
Shamrock International Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Shamrock International is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Shamrock International Limited, buy the company report.

Financials of Shamrock International Limited

FY 2025 filings available

Shamrock International Limited reported revenue of ₹7.47 Cr (up 93% YoY) for FY 2025.

Revenue · FY 2025
₹7.47 Cr ▲ 93%
Net profit · FY 2025
₹34.58 Lakh margin 4.6%
EBITDA · FY 2025
₹70.41 Lakh margin 9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 93%
3 years · compounded
▲ 25%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 235%
5 years · compounded
▼ 18%

Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 93% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹70.41 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹34.58 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.4%
Net Profit Margin4.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shamrock International Limited, buy the company report.

Board of directors of Shamrock International Limited

Shamrock International has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sheetal K KhokhaniDirector21 Jun 20224 Years 4 MonthsCurrent
Kiran Moreshwar MeherDirector07 Sep 20224 Years 2 MonthsCurrent
Jitesh Khokhani RameshchandraDirector01 Aug 199927 Years 3 MonthsCurrent

Auditor

Shamrock International Limited is audited by R SONI & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
R SONI & COFY 2022133240

Shareholding

The shareholding of Shamrock International Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Shamrock International Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Shamrock International Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Shamrock International has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACS5756L1ZWMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Shamrock International Limited, buy the company report.

Recent activity

Shamrock International Limited has 7 board changes on record since 1999: 3 appointments and 4 cessations. The latest: Kiran Moreshwar Meher ceased to be Additional Director on 30 Sep 2022.

AGM
Shamrock International Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Shamrock International Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Kiran Moreshwar Meher ceased to be Additional Director.
Ceased
Chandrakant Champaklal Chokshi ceased to be Director.
Appointed
Kiran Moreshwar Meher was appointed as Director.
Ceased
Ketan Bhupendrabhai Parikh ceased to be Additional Director.
Appointed
Sheetal K Khokhani was appointed as Director.
Ceased
Sheetal K Khokhani ceased to be Director.
Appointed
Jitesh Khokhani Rameshchandra was appointed as Director.
Incorporation
15 Mar 1994
Shamrock International Limited was registered on 15 Mar 1994 with Roc Mumbai & aged 32 years 8 months as per MCA records.

Frequently asked questions

Shamrock International is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 1994 (32+ years old) and is registered under CIN U51900MH1994PLC077080.

Shamrock International has 3 current directors:

The latest financial statements of Shamrock International on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Shamrock International is 27AAACS5756L1ZW, registered in Maharashtra.

The CIN (Corporate Identification Number) of Shamrock International is U51900MH1994PLC077080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shamrock International has 31 court cases on record: 13 filed by the company and 18 filed against it. 2 are pending. Most are in the high courts.

Shamrock International was incorporated on 15 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.

Kiran Moreshwar Meher ceased to be Additional Director on 30 Sep 2022. Chandrakant Champaklal Chokshi ceased to be Director on 07 Sep 2022. Kiran Moreshwar Meher was appointed as Director on 07 Sep 2022. Shamrock International has 7 board changes on record in total.

The registered office of Shamrock International is at 0 – 2 Floor – 0 1B Vrindavan Chs Laxminarsingh Papan Marg Off. Dr. E. Moses Road Gandhi Naga, R Worli, Mumbai, Maharashtra, India – 400018.

Shamrock International operates in the pharma industry, in the drug formulation and development segment.